REDD1 is a determinant of the sensitivity of renal cell carcinoma cells to autophagy inhibition that can be therapeutically exploited by targeting PIM activityJennifer S. Carew, Steffan T. Nawrocki, Claudia M. Espitia et al.|Cancer Letters|2025Cited by 8
Targeting autophagy: A promising approach for the treatment of breast cancer brain metastasesSteffan T. Nawrocki, Jennifer S. Carew, Claudia M. Espitia et al.|Clinical and Translational Discovery|2024Cited by 1
Figure 3 from p97 Inhibition Synergistically Enhances Hypomethylating Therapy through Targeting of PLK1 in Acute Myeloid LeukemiaSteffan T. Nawrocki, Kevin R. Kelly, Ning Wang et al.|Unknown|2026Cited by 0
Supplemental Table S1 from p97 Inhibition Synergistically Enhances Hypomethylating Therapy through Targeting of PLK1 in Acute Myeloid LeukemiaSteffan T. Nawrocki, Kevin R. Kelly, Ning Wang et al.|Unknown|2026Cited by 0
Figure 4 from p97 Inhibition Synergistically Enhances Hypomethylating Therapy through Targeting of PLK1 in Acute Myeloid LeukemiaSteffan T. Nawrocki, Kevin R. Kelly, David L. Drum et al.|Unknown|2026Cited by 0